Please use this identifier to cite or link to this item: https://doi.org/10.2174/092986710793361270
Title: Neurochemistry changes associated with mutations in familial Parkinson's disease
Authors: Siddique M.M.
Tan E.K. 
Keywords: Apoptosis
Mitochondrial dysfunction
Parkinson's disease (PD)
Protein aggregation
Issue Date: 2010
Citation: Siddique M.M., Tan E.K. (2010). Neurochemistry changes associated with mutations in familial Parkinson's disease. Current Medicinal Chemistry 17 (35) : 4378-4391. ScholarBank@NUS Repository. https://doi.org/10.2174/092986710793361270
Abstract: Parkinson's disease (PD), a common neurodegenerative disease, is characterized by the progressive loss of dopamine neurons and the accumulation of Lewy bodies and neurites. The exact role of genetic and environmental factors in the pathogenesis of PD has frequently been debated. The association of MPTP (methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and toxins (such as rotenone) with parkinsonism highlights the potential etiologic role of environmental toxins in disease causation. The recent discoveries of monogenic (such as ?-synuclein, Parkin, UCHL1, PINK1, DJ-1, LRRK2) forms of PD have provided considerable insights into its pathophysiology. Parkin, an ubiquitin protein ligase assists in the degradation of toxic substrates via the ubiquitin proteasome system. It can also mediate a nondegradative form of ubiquitination. PINK1 and LRRK2 are possibly involved in the phosphorylation of substrates important for various cellular functions. Some toxins could interact with ?-synuclein, an endogenous protein that is implicated in pathology of PD. Increasing in vitro and in vivo studies suggest that deficits in mitochondrial function, oxidative and nitrosative stress, the accumulation of aberrant or misfolded proteins, and ubiquitin-proteasome system dysfunction underpin the pathogenesis of sporadic and familial forms of PD. Elucidation of the functions of the proteins encoded by the diseasecausing genes will provide an opportunity for identification of specific pathways that could be targeted in neurotherapeutics. � 2010 Bentham Science Publishers Ltd.
Source Title: Current Medicinal Chemistry
URI: http://scholarbank.nus.edu.sg/handle/10635/148886
ISSN: 9298673
DOI: 10.2174/092986710793361270
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

3
checked on Apr 17, 2019

Page view(s)

19
checked on Jan 17, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.